CMS Open Payments · Program Year 2024
Lumenis BE LTD
Lumenis BE LTD reported $35,537.25 across General Payments, Research, and Ownership to 11 physicians and teaching hospitals across 11 transactions.
- $35.5K Below-median payer
- All-tracks total
- 11 Below-median volume
- Transactions
- 11 Below-median reach
- Recipients
- −$329.4K
- General Payments vs PY2023
Lumenis BE LTD reported $35,537.25 across all CMS Open Payments tracks (General + Research + Ownership) to 11 physicians and teaching hospitals in Program Year 2024 - ranking #1434 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $35,537.25, averaging $3.2K per recipient.
Lumenis BE LTD's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
13/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer lumenis-be-ltd Lumenis BE LTD
$35.5K · #1434/1,925 · 0.0% industry · PY2024
- TOT $35.5K
- RANK #1434
- SHARE 0.0%
- TXN 11
- RCP 11
- CAT 2
- GEN $35.5K
- ΔGEN −$329.4K
- TOP1 44.5%
- PY 2024
Volume peers
Nearest volume peer: Atlas Ocular, Inc ($35.4K)
Lumenis BE LTD sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Lumenis BE LTD's CMS-reported General Payments decreased by $329.4K (−90.3%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: LUMENIS BE LTDPY2023: LUMENIS BE LTDPY2024: Lumenis BE LTD. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $364,900.48
- PY2024
- $35,537.25
What the Data Shows for Lumenis BE LTD
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Lumenis BE LTD that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
Of the 2 general-payment categories charted below, "Honoraria" is the largest at $34.0K across 10 transactions, 95.8% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Lumenis BE LTD made 2 types of general payments. "Honoraria" is the largest category at $34.0K, 95.8% of General Payments.
How Lumenis BE LTD divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Honoraria | $34.0K | 10 | 95.8% |
| Food and Beverage | $1.5K | 1 | 4.2% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $35,537.25 (100.0%) of $35,537.25 in this company's General Payments records across 5 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Lumenis BE LTD
The five named recipients with the highest reported General Payments from this company
- 1
David Rapaport
$15,807.17 across 5 reported transactions
- 2
Rolando Toyos
$10,330.08 across 1 reported transactions
- 3
Macrene Alexiades-Armenakas
$4,500.00 across 1 reported transactions
- 4
Marc Avram
$3,400.00 across 3 reported transactions
- 5
Arielle Kauvar
$1,500.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Lumenis BE LTD ranks #1434 of 1,925 by total payments (bottom 26% by spend) but is notably more concentrated than that alone would suggest -- #555 of 1,838 by HHI (top 30% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Levita Magnetics International Corp. : $2.4K total payments, HHI 3174
- Perspectum Diagnostics Ltd : $1.1M total payments, HHI 3165
- Veru Inc. : $149.5K total payments, HHI 3151
- Merete Technologies, Inc : $72.1K total payments, HHI 3135
- Vifor (International) Ltd. : $132.0K total payments, HHI 3112
- Asklepios Biopharmaceutical Inc. : $7.6M total payments, HHI 3111
- Lumenis BE LTD (this company) : $35.5K total payments, HHI 3093
- Republic Spine : $567.3K total payments, HHI 3085
- Cook Research Incorporated : $288.6K total payments, HHI 3073
- Delphinus Medical Technologies, Inc. : $435.0K total payments, HHI 3070
- Perfuze Limited : $36.4K total payments, HHI 3056
- Medicaroid, Inc. : $3.1K total payments, HHI 3056
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Lumenis BE LTD's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Lumenis BE LTD.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Lumenis BE LTD.
Showing 6 of 1,924 companies with CMS-reported payment data.
Heraeus Medical, LLC.
Therakos Healthcare LLC
Eminent Spine, LLC
Den-Mat Holdings, LLC
Canon Medical Informatics, Inc.
Put this to use
Lumenis BE LTD ranks #1434 of 1,925 by all-tracks total payments, led by "Honoraria".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Honoraria" spend across every manufacturer, not just Lumenis BE LTD. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.